Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Todos Med Ltd. (TOMDF) Message Board

PR and some answers below... Todos Medical Esta

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 1418
(Total Views: 214)
Posted On: 08/31/2022 2:33:21 PM
Avatar
Posted By: redspeed
PR and some answers below...

Todos Medical Establishes Botanical Supplement Manufacturing Capabilities to Support Tollovid Global Expansion and Initiates CBD-A Production
August 31, 2022 09:11 ET

https://www.globenewswire.com/news-release/20...ction.html

Gerald Commissiong@G_Commish
$TOMDF - we’ve filed trademark for #TollovidComplete to cover next-gen formulation to include #Tollovid, CBD-A, Vitamin C and other key immune support ingredients. We’ll be expanding formulations including drinks and gummies in the future. We heard from parents who want options.
11:39 AM · Aug 31, 2022


Gerald Commissiong@G_Commish 1h
It’s not an investment really. We are cash positive out of the gate from CBD extraction and finished product white label. So from cash standpoint no drain, and it allows us to prepare for when we get that claim. Absolutely we expect demand to jump when the influencers kick in


Gerald Commissiong@G_Commish 1h
Hempori may distribute some of the products, but other than that for the time being no. Two separate companies. Ultimately that could change, but there are no plans now.


Gerald Commissiong@G_Commish 49m
We are aware. We will have multiple products and definitely are not stopping production of Tollovid standalone. With that said, we have strong reason to believe that the viral entry aspects, over a short period, can be helpful in getting people who don’t product nAb over the hump


Gerald Commissiong@G_Commish 35m
No problem. It’s understandable that this move isn’t immediately clear to everyone, but I think once you understand the botanicals market this makes a lot of sense. CBD market has nothing unique in it. Tollovid combo is easy sell to those buyers & mechanism of CBD-A complementary





(1)
(0)




Todos Med Ltd. (TOMDF) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us